Dostupnost' Lekarstv V Kyrgyzstane I Faktory, Vliyayushchie Na Neye
| AUTHOR | Sabirova Tamara; Tashbulatova Naila |
| PUBLISHER | LAP Lambert Academic Publishing (11/02/2011) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
V Kyrgyzstane ostro stoyat problemy dostupnosti lekarstvennykh sredstv i neetichnogo prodvizheniya lekarstvennykh sredstv. Ustanovleno, chto v TsSM stolitsy Kyrgyzstana prakticheski vse vrachi stalkivalis' v svoey rabote s meditsinskimi predstavitelyami farmatsevticheskikh kompaniy, v regionakh strany eta tsifra dostigaet 66%. Po rezul'tatam analiza vypiski retseptov i tendernykh dokumentov na zakupki lekarstvennykh sredstv v lechebno-profilakticheskikh organizatsiyakh ustanovleno, chto aktivnoe prodvizhenie brendovykh preparatov meditsinskimi predstavitelyami farmatsevticheskikh kompaniy privodit k naznacheniyu vrachami patsientam bolee dorogikh lekarstv i preparatov s nedokazannoy effektivnost'yu, chto sposobstvuet snizheniyu dostupnosti lekarstv, uvelichivaet gosudarstvennye raskhody na lechenie patsientov-l'gotnikov i privodit k neratsional'nomu ispol'zovaniyu lekarstv i byudzhetnykh sredstv.
Show More
Product Format
Product Details
ISBN-13:
9783846544723
ISBN-10:
3846544728
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
Russian
More Product Details
Page Count:
68
Carton Quantity:
116
Product Dimensions:
6.00 x 0.16 x 9.00 inches
Weight:
0.25 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | General
Descriptions, Reviews, Etc.
publisher marketing
V Kyrgyzstane ostro stoyat problemy dostupnosti lekarstvennykh sredstv i neetichnogo prodvizheniya lekarstvennykh sredstv. Ustanovleno, chto v TsSM stolitsy Kyrgyzstana prakticheski vse vrachi stalkivalis' v svoey rabote s meditsinskimi predstavitelyami farmatsevticheskikh kompaniy, v regionakh strany eta tsifra dostigaet 66%. Po rezul'tatam analiza vypiski retseptov i tendernykh dokumentov na zakupki lekarstvennykh sredstv v lechebno-profilakticheskikh organizatsiyakh ustanovleno, chto aktivnoe prodvizhenie brendovykh preparatov meditsinskimi predstavitelyami farmatsevticheskikh kompaniy privodit k naznacheniyu vrachami patsientam bolee dorogikh lekarstv i preparatov s nedokazannoy effektivnost'yu, chto sposobstvuet snizheniyu dostupnosti lekarstv, uvelichivaet gosudarstvennye raskhody na lechenie patsientov-l'gotnikov i privodit k neratsional'nomu ispol'zovaniyu lekarstv i byudzhetnykh sredstv.
Show More
Your Price
$62.84